Turning Poo Into Insights.

We aspire to build the Poodl.

A portable scanner for monitoring the quality of digestion and detecting health states that correspond with changes in the stool. A convenient and easy-to-use home-monitoring solution combined with tele-health services. 

After promising feasibility studies, we currently identify the most promising target population and will start validation studies soon.


A healthy bowel takes it all. Otherwise, something is wrong.
bad quality of digestion is a sign for:

  • Malabsorption and / or Maldigestion due to:

    • Inflammation  or Irritation of the bowel 

    • Short Bowel Syndrome / Celiac disease / Pancreatic insufficiency / Lack of bile acids

  • Change in Nutrition (e.g. High Protein Diet)

  • Unsuitable Enteral Nutrition (e.g. after an accident)

also neurological or neurodegenerative diseases such as Alzheimer´s Disease, Multiples Sclerosis, or Depression are associated with the bowel.

Market Potential

  • More than 1.4 million people in Germany, primarily women, are diagnosed with Irritable Bowel Syndrom or Inflammatory Bowel Disease. 7-16% of the total population struggles with symptoms of an Irritable Bowel Syndrom, a similar prevalence for Europe and the United States.
  • Overall annual healthcare expenditures in U.S. for gastrointestinal disease total $136 billion. 
  • Abdominal pain is the symptom most responsible for 22 million office visits and 6 million emergency department (ED) visits in the U.S.
  • There is an $18 billion market forecast for IoT & diagnostics by 2020 according to Forbes.
  • US market research analysts estimate the stool testing market to surpass US$ 720 million by 2019 due to the growing awareness of diagnostic stool test among the people.


  • Qualification & Quantification of scientific parameter & pattern
  • Objective data for the user, patient or healthcare professionals
  • Enabling personalized therapy
  • Nutrition optimization or diet adjustment

  • Increase Quality of Life (QoL), the energy level and productivity for patients
  • Avoiding painful phases of patients
  • Reduction of Healthcare burdens & hospitalization costs
  • Reduction of steroids like cortisone.

Potential Customers

  • People who suffer from gastrointestinal diseases, like Inflammatory bowel disease or Irritable bowel syndrome, who want more insights about their digestive health and want to home-monitor their stool
  • Parents who wish to gain insights into their child’s digestive health
  • Providers who want to personalize enteral nutrition for patients
  • Payers which want to avoid hospitalization costs and allocate resources more effective

Our Call

We are raising, get in touch: hello@poodl.io
20% refund of your investement by BAFA


Lutz Haase, MBA
Founder & CEO

10+ years of digital health consulting for e.g. Bayer, Biotronik or Roche Diagnostics. Angel Investor.

Dr. Jan Kunde
Founder & CSO

15+ years of medical affairs within Bayer, Thermo Fisher Scientific, Takeda or Epigenomics.

Dr. Hardy Kietzmann

20+ years in Healthcare & Pharma in the fields of innovation, business development and strategy.

Prof. Dr. Andreas Schwiertz (Advisor)

Head of R&D at MVZ Institute of Microecology & Microbiome Expert


Institute of Microecology
The specialist for microbiota and mucosal surface.


Center for biomedical image and information processing
HTW Berlin

“In 30 years from now, people will say: What?! You didn’t measure your poo regularly?!”